Tel:
Fax:
Email:
Creative Biolabs

Mouse Anti-ND4 Monoclonal Antibody (CBP3077)

[CAT#: NAB-0720-Z5502]

ND4 Mouse Monoclonal Antibody

Host Species:
Mouse
Species Reactivity:
Human
Applications:
WB

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Immunogen

Synthetic peptide corresponding to Human ND4 (N terminal).
Database link: P03905

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Isotype

IgG2a, kappa

Clone Number

CBP3077

Applications

WB

Relevant Diseases

Parkinson's Disease

Pathways

Parkinson's Disease Signaling

Marker

Others

Conjugation

Unconjugated
Product Properties

Formulation

pH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 0.36% HEPES, 0.87% Sodium chloride

Purification

Protein L purified

Purity

>95%

Shipping

Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

Storage

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Notes: avoid repeated freeze-thaw cycles.

Research Use Only

For research use only, not for diagnostic or therapeutic use.
Target

Target

ND4

Official Name

ND4

Full Name

MT-ND4

Alternative Names

ND4; MTMT-NADH dehydrogenase; subunit 4 (complex I)

Gene ID

4538(Human)

Uniprot ID

P03905(Human)
Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar

The Spectrum of Stem Cell-Based Neuronal Models and Their Fit for Purpose

2:00 PM–3:00 PM EST, December 12, 2024

REGISTER NOW
Inquiry Basket
compare

Send inquiry